Upregulation of retinol-binding protein 4 (RBP4) in human blood serum is linked with insulin resistance, the development of T2DM, and such clinical manifestations of metabolic syndrome as obesity, glucose intolerance, dyslipidemia, and hypertension [111,112]. Here, RBP4 is linked to Insulin resistance.